DermTech Management to Present at Upcoming Investor Conferences

Rhea-AI Summary

DermTech (NASDAQ: DMTK) has announced management presentations at two upcoming healthcare conferences. The Cowen 42nd Annual Health Care Conference will take place on March 8, 2022, at 12:50 p.m. Eastern Time, followed by the Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022, at 3:20 p.m. Eastern Time. Interested parties can access live webcasts and archived presentations via DermTech’s website. The company is focused on precision dermatology through non-invasive skin genomics, aiming to improve skin cancer detection and customize treatments for inflammatory diseases.

LA JOLLA, Calif.--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that its management will present at the following upcoming conferences:

• Cowen 42nd Annual Health Care Conference
  Presenting on Tuesday, March 8, 2022 at 12:50 p.m. Eastern Time

• Oppenheimer 32nd Annual Healthcare Conference
  Presenting on Tuesday, March 15, 2022 at 3:20 p.m. Eastern Time

Interested parties may access the live webcasts of the presentations and, for 90 days following the Cowen and Oppenheimer conferences, the archived webcasts of the presentations through the “Investor Relations” section of DermTech’s website at: www.DermTech.com.

About DermTech:
DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by our non-invasive skin genomics platform. DermTech's mission is to transform dermatology with our non-invasive skin genomics platform, to democratize access to high quality dermatology care, and to improve the lives of millions. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers and is developing products that assess inflammatory diseases and customize drug treatments. For additional information on DermTech, please visit DermTech's investor relations site at: www.dermtech.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220224005265/en/

DermTech

Sarah Dion

sdion@dermtech.com

858.450.4222



ICR Westwicke IR

Caroline Corner, PhD

caroline.corner@westwicke.com

415.202.5678

Source: DermTech, Inc.

FAQ

When will DermTech present at the Cowen 42nd Annual Health Care Conference?

DermTech will present at the Cowen 42nd Annual Health Care Conference on March 8, 2022, at 12:50 p.m. Eastern Time.

What is the date for DermTech's presentation at the Oppenheimer 32nd Annual Healthcare Conference?

DermTech will present at the Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022, at 3:20 p.m. Eastern Time.

How can I access DermTech's conference presentations?

You can access DermTech's live webcasts and archived presentations through the Investor Relations section of their website at www.DermTech.com.

What is DermTech's focus in dermatology?

DermTech focuses on precision dermatology enabled by a non-invasive skin genomics platform, aiming to improve skin cancer detection and treatment customization.

What is the stock symbol for DermTech?

The stock symbol for DermTech is DMTK.